Attached files
file | filename |
---|---|
10-K - Talon Therapeutics, Inc. | v215484_10k.htm |
EX-31.2 - Talon Therapeutics, Inc. | v215484_ex31-2.htm |
EX-31.1 - Talon Therapeutics, Inc. | v215484_ex31-1.htm |
EX-23.1 - Talon Therapeutics, Inc. | v215484_ex23-1.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 200 2
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Talon Therapeutics, Inc. do hereby certify that to the best of his knowledge:
(a) the Annual Report on Form 10-K of Talon Therapeutics, Inc. for the year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Talon Therapeutics, Inc.
Dated: March 28, 2011
|
By:
|
/s/ Steven R. Deitcher
|
Steven R. Deitcher, M.D.
|
||
President & Chief Executive Officer
|
Dated: March 28, 2011
|
By:
|
/s/ Craig W. Carlson
|
Craig W. Carlson
|
||
Senior Vice President, Chief Financial Officer
|